Evidence-based medicine criteria applied to hypolipidemic and antihypertensive drug trials: Is drug efficacy always the same?

被引：3

作者：

Calabresi, L ^{[1
]}

Sirtori, CR ^{[1
]}

机构：

[1] Univ Milan, Inst Pharmacol Sci, Ctr E Grossi Paoetti, I-20133 Milan, Italy

来源：

PHARMACOLOGICAL RESEARCH | 1998年 / 37卷 / 05期

关键词：

D O I：

10.1006/phrs.1998.0308

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：339 / 343

页数：5

共 19 条

[1] Simvastatin in the secondary prevention of coronary heart disease [J].

Assmann, G .

PHARMACOLOGICAL RESEARCH, 1997, 35 (03) :161-161

[2] Stroke, statins, and cholesterol - A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors [J].

Blauw, GJ ;

Lagaay, AM ;

Smelt, AHM ;

Westendorp, RGJ .

STROKE, 1997, 28 (05) :946-950

[3] EFFECT OF PARTIAL ILEAL BYPASS-SURGERY ON MORTALITY AND MORBIDITY FROM CORONARY HEART-DISEASE IN PATIENTS WITH HYPERCHOLESTEROLEMIA - REPORT OF THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERLIPIDEMIAS (POSCH) [J].

BUCHWALD, H ;

VARCO, RL ;

MATTS, JP ;

LONG, JM ;

FITCH, LL ;

CAMPBELL, GS ;

PEARCE, MB ;

YELLIN, AE ;

EDMISTON, WA ;

SMINK, RD ;

SAWIN, HS ;

CAMPOS, CT ;

HANSEN, BJ ;

TUNA, N ;

KARNEGIS, JN ;

SANMARCO, ME ;

AMPLATZ, K ;

CASTANEDAZUNIGA, WR ;

HUNTER, DW ;

BISSETT, JK ;

WEBER, FJ ;

STEVENSON, JW ;

LEON, AS ;

CHALMERS, TC .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :946-955

[4] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].

COLLINS, R ;

PETO, R ;

MACMAHON, S ;

HEBERT, P ;

FIEBACH, NH ;

EBERLEIN, KA ;

GODWIN, J ;

QIZILBASH, N ;

TAYLOR, JO ;

HENNEKENS, CH .

LANCET, 1990, 335 (8693) :827-838

[5]

COLLINS R, 1994, TXB HYPERTENSION, P1150

[6] THE NUMBER NEEDED TO TREAT - A CLINICALLY USEFUL MEASURE OF TREATMENT EFFECT [J].

COOK, RJ ;

SACKETT, DL .

BRITISH MEDICAL JOURNAL, 1995, 310 (6977) :452-454

[7] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[8]

ISLES C, 1997, ATHEROSCLEROSIS ID R, V2, P89

[9] PERSANTINE-ASPIRIN REINFARCTION STUDY .2. SECONDARY CORONARY PREVENTION WITH PERSANTINE AND ASPIRIN [J].

KLIMT, CR ;

KNATTERUD, GL ;

STAMLER, J ;

MEIER, P .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) :251-269

[10] Secondary prevention for ischemic heart disease - Relative numbers needed to treat with different therapies [J].

Miller, DB .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (18) :2045-2052

← 1 2 →